The progression of artificial intelligence in healthcare has largely occurred in silos, with innovations developing within specific medical domains, rather than across them.
For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly regulated, dynamic industry – and it’s only becoming more complicated